Document Detail

Identification of an antagonistic probiotic combination protecting ornate spiny lobster (Panulirus ornatus) larvae against Vibrio owensii infection.
Jump to Full Text
MedLine Citation:
PMID:  22792184     Owner:  NLM     Status:  MEDLINE    
Vibrio owensii DY05 is a serious pathogen causing epizootics in the larviculture of ornate spiny lobster Panulirus ornatus. In the present study a multi-tiered probiotic screening strategy was used to identify a probiotic combination capable of protecting P. ornatus larvae (phyllosomas) from experimental V. owensii DY05 infection. From a pool of more than 500 marine bacterial isolates, 91 showed definitive in vitro antagonistic activity towards the pathogen. Antagonistic candidates were shortlisted based on phylogeny, strength of antagonistic activity, and isolate origin. Miniaturized assays used a green fluorescent protein labelled transconjugant of V. owensii DY05 to assess pathogen growth and biofilm formation in the presence of shortlisted candidates. This approach enabled rapid processing and selection of candidates to be tested in a phyllosoma infection model. When used in combination, strains Vibrio sp. PP05 and Pseudoalteromonas sp. PP107 significantly and reproducibly protected P. ornatus phyllosomas during vectored challenge with V. owensii DY05, with survival not differing significantly from unchallenged controls. The present study has shown the value of multispecies probiotic treatment and demonstrated that natural microbial communities associated with wild phyllosomas and zooplankton prey support antagonistic bacteria capable of in vivo suppression of a pathogen causing epizootics in phyllosoma culture systems.
Evan F Goulden; Michael R Hall; Lily L Pereg; Lone Høj
Related Documents :
23422414 - Role of imaging in the diagnosis and management of parasitic infections.
22547394 - The role of chemokines in the pathogenesis of neurotropic flaviviruses.
22918844 - Chronic bartonellosis in cats: what are the potential implications?
1163884 - Comparative study of mycoplasma pulmonis and mycoplasma gallisepticum infections in tur...
21995284 - Inflammasome activation via intracellular nlrs triggered by bacterial infection.
19889264 - Model for end-stage liver disease (meld) score as a useful prognostic marker in cirrhot...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-07-05
Journal Detail:
Title:  PloS one     Volume:  7     ISSN:  1932-6203     ISO Abbreviation:  PLoS ONE     Publication Date:  2012  
Date Detail:
Created Date:  2012-07-13     Completed Date:  2013-03-19     Revised Date:  2013-07-12    
Medline Journal Info:
Nlm Unique ID:  101285081     Medline TA:  PLoS One     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e39667     Citation Subset:  IM    
Australian Institute of Marine Science, Townsville, Queensland, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Larva / immunology,  microbiology
Palinuridae / immunology,  microbiology*
Vibrio / genetics,  isolation & purification,  physiology*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): PLoS One
Journal ID (iso-abbrev): PLoS ONE
Journal ID (publisher-id): plos
Journal ID (pmc): plosone
ISSN: 1932-6203
Publisher: Public Library of Science, San Francisco, USA
Article Information
Download PDF
Goulden et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received Day: 23 Month: 2 Year: 2012
Accepted Day: 24 Month: 5 Year: 2012
collection publication date: Year: 2012
Electronic publication date: Day: 5 Month: 7 Year: 2012
Volume: 7 Issue: 7
E-location ID: e39667
ID: 3390342
PubMed Id: 22792184
Publisher Id: PONE-D-12-05907
DOI: 10.1371/journal.pone.0039667

Identification of an Antagonistic Probiotic Combination Protecting Ornate Spiny Lobster (Panulirus ornatus) Larvae against Vibrio owensii Infection Alternate Title:Antagonistic Probionts of Panulirus ornatus Larvae
Evan F. Goulden12
Michael R. Hall1
Lily L. Pereg2
Lone Høj1*
Mark R. Lilesedit1 Role: Editor
1Australian Institute of Marine Science, Townsville, Queensland, Australia
2Research Centre for Molecular Biology, School of Science and Technology, University of New England, Armidale, New South Wales, Australia
Auburn University, United States of America
Correspondence: * E-mail:
Contributed by footnote: Conceived and designed the experiments: EFG MRH LLP LH. Performed the experiments: EFG LH. Analyzed the data: EFG LH. Contributed reagents/materials/analysis tools: EFG LH. Wrote the paper: EFG MRH LLP LH.


The ornate spiny lobster (Panulirus ornatus) is considered a prospective aquaculture species based on encouraging grow-out potential [1] and lucrative market value [2]. However, closed-life cycle production of P. ornatus is currently commercially unviable due to restricted production of postlarvae resulting from nutritional deficits and bacterial disease during their 4–6 month long larval phase [3][7]. Vibrio owensii is an emerging pathogen, with the type strain DY05 demonstrated as the etiological agent of a disease causing mass mortalities of cultured P. ornatus larvae (phyllosomas) [7], [8]. The pathogen can be transmitted through live feed vectors (Artemia) and proliferates in the phyllosoma hepatopancreas (midgut gland), causing extensive tissue necrosis and eventually major systemic infection [7].

In view of the global antibiotic resistance crisis [9] there is considerable interest in developing sustainable biocontrol methods such as probiotics for disease management in aquaculture [10]. The search for probionts is based on screening for beneficial microbial attributes such as antagonism, predation, anti-virulence, competition, attachment to host surfaces, and immunostimulation [10][14]. We have previously shown that the planktonic form is central to vectored transmission of V. owensii DY05 [7], hence it was pertinent to investigate the ability of probiotic candidates to inhibit planktonic growth. Moreover, since biofilms are refuges for pathogens in aquaculture systems [15], [16] and pathogen biofilms on natural tissues are inherently tolerant to conventional antimicrobial therapies [17], we also wanted to investigate the ability of probiotic candidates to inhibit biofilm formation under conditions of exclusion, competition and displacement.

Here we present a multi-tiered screening strategy for probiotic candidates, which ultimately led to the identification of a two-strain combination providing efficient protection of phyllosomas against experimental V. owensii DY05 infection. Initially, a shortlist of probiotic candidates was generated from a large pool of bacteria showing in vitro antagonism towards V. owensii DY05. Two additional in vitro screens were developed using a green fluorescent protein (GFP)-transconjugant of the pathogen to assess its planktonic growth and biofilm formation in the presence of shortlisted candidates. Subsequently, promising candidates were assessed for inherent virulence and protective benefit in vivo using a P. ornatus phyllosoma experimental infection model.

Materials and Methods
Replica Plate Assay

Wild Panulirus spp. phyllosomas and putative zooplankton prey items (not endangered or protected) were collected at Osprey Reef (Coral Sea, Australia; 13° 56′S, to 14° 03′ S and 144° 26′ E to 146° 48′ E) between 24 May-9 June 2008. No specific permits were required as the sites were located in the Australian Exclusive Economic Zone outside the Great Barrier Reef Marine Park and were not protected. Capture was achieved using a modified Isaac-Kidd mid-water trawl net according to Smith et al. [3]. Briefly, animals were washed 3× in 0.22 µm filtered artificial sea water (ASW; Instant Ocean®) to remove debris and loosely attached epibionts, homogenised in ASW, and spread plated on minimal marine agar (MMA; 0.3% casamino acids; 0.4% glucose; 1% bacteriological agar in 1 L ASW), modified from Hjelm et al. [18]. After incubation at ambient temperature (24°C) for 24–48 h, MMA plates with <300 colonies were replica plated [18] onto MMA seeded with 10 µL mL−1 of V. owensii DY05 grown overnight (24°C, 170 rpm) in marine broth 2216 (MB; BD). Replica plates were incubated for 72 h (24°C) and inspected for inhibition zones signifying antagonistic activity against V. owensii DY05. Antagonistic colonies were picked and cultured to purity on MMA, re-cultured in MB overnight (28°C, 170 rpm), and cryopreserved in 30% (v/v) glycerol (−80°C).

Well-diffusion Agar Assay (WDAA)

Antagonistic isolates recovered from replica plates and the Australian Institute of Marine Science (AIMS) culture collection were tested for growth-inhibitory activity against V. owensii DY05 in a well diffusion agar assay (WDAA). In brief, the pathogen was seeded into molten MMA as outlined above. Following solidification, wells (diameter 5 mm) were cut into the agar and loaded with 40 µL of dense cultures (1–3 day old) of test isolates grown in MB (28°C, 170 rpm). Plates were incubated (28°C) and observed every 24 h for 72 h for inhibition zones. Phaeobacter (formerly Roseobacter) strain 27-4 was used as a positive antagonistic control on each plate because of its broad spectrum inhibitory activity against Vibrio pathogens [18][20]. Antagonism was classified according to the size of the inhibition zones as low (5–10 mm), moderate (11–20 mm) or strong (≥21 mm).

Phylogenetic Identification

Colony PCR was performed on antagonistic isolates with universal primers 27F and 1492R [21] under standard conditions. PCR products were purified and sequenced using 27F (all strains) and 1492R (16 shortlisted candidates) as sequencing primers by Macrogen (Seoul, Korea). Sequences were edited with Sequencher 5.0 software (GeneCodes Corporation) and analysed using the BLAST algorithm ( to determine nucleotide-nucleotide similarity with sequences in the nr/nt database. Isolates were grouped according to phylogenetic relatedness by partial 16S rRNA gene sequence alignment using MEGA4 [22]. For the 16 shortlisted candidates sequences were submitted to GenBank under accession numbers JX075050–JX075065.

Inoculum Preparation

A GFP-labelled transconjugant of V. owensii DY05 (DY05[GFP]) was used as a proxy for pathogen growth and attachment in microgrowth co-culture and multispecies biofilm assays, respectively (described below). DY05[GFP] stably expresses the GFP, and does not differ in growth profile or virulence towards stage 1 P. ornatus phyllosomas compared to wild type V. owensii DY05 [7].

DY05[GFP] was cultured on LB20 agar plates (5 g L−1 yeast extract; 10 g L−1 neutralised peptone; 20 g L−1 NaCl; 15 g L−1 agar) supplemented with 40 µg mL−1 kanamycin and 50 µg mL−1 colistin. Probiotic candidates and wild type V. owensii DY05 were cultured on marine agar 2216 (MA) at 28°C for 24 h. For each strain, colony material was suspended in 2 mL phosphate buffered saline (PBS: 8 g L−1 NaCl; 0.2 g L−1 KCl; 1.44 g L−1 Na2HPO4; 0.24 g L−1 KH2PO4; pH 7.2) and absorbance adjusted to OD600 nm 0.1 (Nanodrop ND1000). The corresponding total viable counts (expressed as CFU mL−1) were determined for each strain in triplicate initial experiments by spiral plating (Eddy Jet; IUL) on MA and enumeration by an automatic colony counter (Flash and Grow v1.2; IUL). This information was used to calculate the volume of each OD600 nm 0.1 suspension needed to achieve desired starting concentrations for the assays described below.

Microgrowth Co-culture Assay

The relationship between fluorescence and CFU mL−1 of V. owensii DY05[GFP] monocultures was tested using the Pearson correlation coefficient. Triplicate samples were withdrawn from the microgrowth assay (described below) at 4 h intervals and there was a strong positive correlation (p<0.0001) between fluorescence and pathogen growth for the first 24 h (Figure S1). This showed that the fluorescence signal generated by V. owensii DY05[GFP] could be used to indirectly quantify pathogen growth during 24 h co-culture with probiotic candidates.

To assess the activity of planktonic candidates, MB was inoculated with PBS suspensions of V. owensii DY05[GFP] (initial concentration 1×103 CFU mL−1) separately or in combination with PBS suspensions of candidate probiotics (final concentrations 1×103, 1×105, or 1×107 CFU mL−1) in Nunc™ (NUN137101) black microwell plates (final volume 200 µL). Separate plates were used for each candidate-pathogen combination and all treatments were performed in hextuplicate well sets. Sterile milli-Q water (200 µL) was added to perimeter rows and columns to minimise evaporative loss and plate covers were treated with 0.1% Triton X-100 in 20% ethanol to smooth condensation [23]. Plates were sealed with parafilm and incubated for 24 h (28°C, 170 rpm). Growth of the GFP-tagged pathogen was monitored indirectly by measuring fluorescence (excitation/emission 485/520 nm) with a Wallac Victor2 1420 multilabel counter. Fluorescence values were adjusted by subtracting the average autofluorescence generated from corresponding controls (wild type V. owensii DY05 monocultures or co-cultures).

The antagonistic activity of each strain was classified based on their ability to reduce the pathogen fluorescence signal after 24 h relative to the maximum signal reduction recorded for the respective assay. In this way, strain antagonistic activity was classified as low (<50% of max), moderate (50–75% of max), or strong (>75% of max).

Biofilm Assays

Monostrain biofilm production by the pathogen and candidate probionts was quantified using a microwell crystal violet (CV) staining assay [24], modified so culture conditions were consistent with other microwell assays used in the present study (Protocol S1). Pathogen biofilm formation in the presence of probiotic candidates was tested under conditions of exclusion, competition, and displacement using a modified attachment assay [25]. The sensitivity of the assay was increased by extending the incubation time from 1 h to the time of maximum biofilm formation by the reporter strain (DY05[GFP]) as determined by the CV assay (t = 48 h and t = 72 h).

For each test, MB was inoculated with PBS suspensions of bacterial strains (each at initial concentration 1×107 CFU mL−1) in Optical bottom Nunc™ (NUN165305) microwell plates (final well volume 200 µL). In all cases the time point for addition of DY05[GFP] was set as t = 0 and plates were incubated statically at 28°C until t = 48 h or t = 72 h. Specifically, for the exclusion assay, half volume MB was inoculated with probiotic candidates and incubated for 24 h prior to inoculation with DY05[GFP] (t = 0 h) and fresh MB. For the competition assay, MB was inoculated simultaneously with DY05[GFP] and probiotic candidates (t = 0 h). For the displacement assay, half volume MB was inoculated with DY05[GFP] (t = 0 h) and incubated for 24 h before inoculation with candidate probionts and fresh MB.

Separate plates were used for each interaction and incubation period and treatments were carried out in hextuplicate well sets. Plates were sealed and treated as described for microgrowth co-culture assay. After incubation, wells were washed 3× in 200 µL PBS to remove planktonic and nonadherent cells. To prevent dehydration, washed wells were loaded with PBS (200 µL). Biofilm attachment was measured as a function of fluorescence and fluorescence values adjusted as described above. Candidates which caused significant signal increase (Student t-test, p<0.05) at any time point were removed from the candidate pool as these were considered pathogen biofilm facilitators. From the remaining observations, the average signal decrease was calculated from the two time points and used to classify the antagonistic activity of each strain as described above.

In vivo Protection against V. owensii DY05 Infection

Selected candidates were tested for inherent pathogenicity towards cultured stage 1 P. ornatus phyllosomas using an infection model described previously [7]. Briefly, phyllosomas were exposed to bacterial strains using live Artemia stage II (nauplii) as vectors. Formalin-disinfected nauplii were enriched with probiotic candidates through filter-feeding in tissue culture flasks (Sarstedt) for 2 h (initial concentration 1×107 CFU mL−1). Positive pathogen control nauplii and negative control nauplii were treated similarly, except 1×106 CFU mL−1V. owensii DY05 or no bacteria were added, respectively. Apparently healthy P. ornatus phyllosomas, as assessed by photopositive response and active motility, were sourced from the AIMS larviculture facility [3], distributed to 12-well cell culture plates (1 larva well−1) and fed live enriched or non-enriched nauplii (t = 0 h). All treatments were performed in quintuplicate (n = 60) and survival was assessed every 24 h for 5 days.

The protective benefit of selected candidates was evaluated in two separate initial experiments using the same probiotic administration strategy (Strategy 1). In brief, stage 1 P. ornatus phyllosomas were fed nauplii enriched with probiotic candidates separately, or in combination (t = 0 h; each candidate at 1×107 CFU mL−1). After 24 h, phyllosomas were challenged with nauplii enriched with 1×106 CFU mL−1V. owensii DY05 for 6 h, after which phyllosomas were transferred to new cell culture plates and again fed nauplii enriched with probiotic candidates (t = 30 h). Subsequently, in a third experiment the most promising candidates were tested using an alternative administration strategy (Strategy 2) which differed from strategy 1 by enriching nauplii with the pathogen in combination with probiotic candidates at t = 24 h (pathogen at 1×106 CFU mL−1; each probiont at 1×107 CFU mL−1). The most promising treatment from the latter experiment was replicated twice to validate observations. All experiments included a negative control (non-enriched nauplii) and a positive pathogen control (nauplii enriched in V. owensii DY05 at t = 24 h; non-enriched nauplii at t = 0 and t = 30 h). All treatments were performed in quintuplicate (n = 60) and survival was assessed every 24 h for 5 days.

Statistical Analysis

Differences between survival curves in the experimental infection models were determined using the product-limit (Kaplan-Meier) estimator and confirmed with an ANOVA. A post hoc Dunnett’s test was used to compare treatments to the defined control groups. All statistical analyses were performed using the statistical software package JMP®7 (SAS) standardised at significance level α = 0.05.

Antagonistic Bacteria

The WDAA confirmed 62 of 149 isolates recovered from replica plating and 29 of 356 culture collection isolates as antagonistic towards V. owensii DY05. The majority of confirmed antagonistic isolates belonged to the genera Pseudoalteromonas (66 isolates; 1 pigmented and 1 non-pigmented phylotype) and Vibrio (16 isolates; 4 phylotypes). The remainder belonged to the Bacteroidetes phylum (2 isolates; 1 phylotype), and the genera Ruegeria (3 isolates; 2 phylotypes), Bacillus (2 isolates; 2 phylotypes), Psychrobacter (1 isolate) and Acinetobacter (1 isolate).

To select antagonistic strains likely capable of interaction with phyllosoma hosts, representatives were shortlisted based on their phylogenetic identity, the strength of their in vitro antagonism in WDAA, and their environmental origin, with preferences given towards natural prey-derived isolates and bacteria associated with P. ornatus phyllosomas or their environments (natural or artificial). Strains that were closely related to known human pathogens or were difficult to keep in pure culture were excluded from further analysis. In this way, the pool of probiotic candidates was reduced to 16 isolates for further in vitro screening (Table S1).

Co-culture Assay

Probiotic candidates were co-cultured with V. owensii DY05[GFP] at three different starting concentrations (Figure 1). At equal starting concentrations (1×103 CFU mL−1), the probiotic candidates had little or no inhibitory effect on pathogen growth, except for the three pigmented Pseudoalteromonas strains (EPP07, K25 and PP107), which demonstrated moderate to strong activity. At higher initial concentration (1×105 CFU mL−1), the candidates generally had increased inhibitory effect, with strong inhibition of pathogen growth observed for the pigmented Pseudoalteromonas strains (EPP07, K25 and PP107) and three of the four Vibrio strains (C013, Ma31, and PP05). At the highest initial concentration (1×107 CFU mL−1), all candidates belonging to the Pseudoalteromonas and Vibrio genera, and Ruegeria strain K2 caused strong growth inhibition, in some instances resulting in total elimination of fluorescent signals. Irrespective of initial concentration, the Bacteroidetes strains (AH26 and PPM04) had minor impact on pathogen growth during co-culture.

Monostrain Biofilm Production

A microwell crystal violet assay was used to study monostrain biofilm production (Figure 2). Attachment of V. owensii DY05 and DY05[GFP] was detected after 24 h but maximum biofilm density was achieved between 48 and 72 h prior to dispersal. Pigmented Pseudoalteromonas strains (EPP07, K25 and PP107) rapidly formed dense biofilms which dispersed after 48 h. Non-pigmented Pseudoalteromonas strains (EPP11, PP86, and PP87) were strong biofilm formers reaching maximum density between 36 and 48 h. Strain PP81 differed from other non-pigmented pseudoalteromonads by rapidly forming and maintaining biofilm density for 48 h until sloughing. Vibrio strains generally produced low density biofilms, with exception of Ma31 which formed a dense and stable biofilm after 12 h. The Ruegeria isolates (AH10, K2, and EPP04) were strong and stable biofilm formers. Bacteroidetes strain PPM04 rapidly formed and maintained a dense biofilm between 12 and 36 h before dispersal, while Bacteroidetes strain AH26 was a weak biofilm producer.

Multistrain Biofilm Assays

A multistrain biofilm assay was used to investigate pathogen biofilm formation in the presence of probiotic candidates under conditions of exclusion, competition and displacement (Figure 3). All non-pigmented Pseudoalteromonas strains (EPP11, PP81, PP86, and PP87), the pigmented Pseudoalteromonas strain EPP07, and Vibrio strain C013 caused significant increases (Student’s t test p<0.05) in fluorescence signals in at least one multistrain interaction, and hence were regarded as biofilm facilitators and eliminated from the candidate pool. In terms of percentage signal reduction, the remaining 10 candidates were more successful at inhibiting pathogen biofilm by exclusion (52–96%; Figure 3a), followed by competition (26–90%; Figure 3b) and displacement (0–37%; Figure 3c). Under conditions of exclusion, the pigmented Pseudoalteromonas strains K25 and PP107, Vibrio strains Ma31 and PP05, and all Ruegeria isolates (AH10, K2 and EPP04) demonstrated strong inhibition. In the competition assay, strong inhibitory activity was shown by two pigmented Pseudoalteromonas strains (K25 and PP107), Vibrio strain PP05 and the Bacteroidetes strains (AH26 and PPM04), and weakest activity exhibited by the Ruegeria candidates AH10, K2 and EPP04. During conditions of displacement, the strongest inhibitory activity was exhibited by two Ruegeria candidates (AH10 and K2) and pigmented Pseudoalteromonas strain K25.

Pathogenicity Testing and in vivo Protective Benefit

The selection of candidates showing strong antagonistic activity under all tested conditions was regarded as the most promising strategy for successful inhibition of the pathogen during in vivo conditions. Based on in vitro screening results the strains Vibrio sp. PP05, Pseudoalteromonas sp. PP107, and Pseudoalteromonas sp. K25 were selected based on their overall superior performance in the well diffusion, microgrowth and biofilm assays. In addition, the best performing Roseobacter clade isolate (Ruegeria sp. K2) was included since many strains belonging to this group of bacteria have elicited promising probiotic effects for other aquaculture species.

An initial experiment tested if the probiotic candidates themselves were pathogenic to phyllosomas. Vectored challenge with PP05, PP107, K25 or K2 (Dunnett’s test p>0.05) did not alter survival of P. ornatus phyllosomas (stage 1) relative to the unchallenged control (Figure 4a) and no anomalous phototactic responses or swimming behaviours were noted, indicating the candidates were non-pathogenic. In comparison, vectored challenge with V. owensii DY05 (pathogen control) caused a significant increase (Dunnett’s test p<0.0001) in phyllosoma mortality (Figure 4a).

The in vivo protective potential of candidates was tested in an experimental setup where probiotic candidates were delivered to phyllosomas via Artemia nauplii before (t = 0 h) and after (t = 30 h) vectored challenge with the pathogen V. owensii DY05 for 6 h (t = 24–30 h) (Strategy 1). Phyllosoma survival was significantly enhanced for candidates PP05 and PP107 (Dunnett’s test p<0.05) compared to the pathogen control (Figure 4b). In contrast, treatment with K25, K2 or a mixture of the four candidates (Dunnett’s test p>0.05) did not significantly enhance survival relative to the pathogen control (Figure 4b). Based on these results, PP05 and PP107 were selected as the most promising candidates and their protective benefit singularly or in combination was further investigated. In the second experiment, survival of PP05 or PP107-treated phyllosomas did not significantly differ from the pathogen control (Dunnett’s test p>0.05) (Figure 4c). However, used in combination the probiotic candidates resulted in a significant (Dunnett’s test p<0.01) benefit, enhancing phyllosoma survival by 30% (Figure 4c).

When the administration strategy was altered so that probionts were present also during the pathogen challenge (t = 24–30 h) (Strategy 2), phyllosoma survival was enhanced by 23% for PP107 (Dunnett’s test p<0.01), by 42% for PP05 (Dunnett’s test p<0.0001), and by 53% for PP05/PP107 in combination (Dunnett’s test p<0.0001) relative to the pathogen control (Figure 4d). The experiment was repeated twice for PP05/PP107 in combination to validate observations (Figure 4e–f), and phyllosoma survival was significantly enhanced by 80% (Dunnett’s test p<0.0001) and 75% (Dunnett’s test p<0.0001) respectively, compared to the pathogen control (Figure 4e–f). It should be noted that survival of PP05/PP107-treated phyllosomas did not differ significantly (Dunnett’s test p>0.05) from non-challenged control phyllosomas in each of the three replicated experiments when nauplii were enriched simultaneously with pathogen and probionts (Figure 4d–f).


The present study has demonstrated that antagonistic bacteria recovered from natural prey items of P. ornatus phyllosomas were capable of protecting cultured phyllosomas from the serious hatchery pathogen V. owensii DY05. The used probiotic screening strategy targeted antagonistic activity by candidate strains in both planktonic and attached forms, resulting in the selection of a two strain combination (Vibrio sp. PP05 and Pseudoalteromonas sp. PP107) that conferred a substantial additive survival benefit to pathogen-challenged phyllosomas.

Antagonism is a widespread trait implicated in the competiveness and ecological success of many marine bacteria [26][29] and is thus considered an important attribute of aquaculture probionts. In the present study, the antagonistic bacteria most readily culturable from wild phyllosomas and zooplankton belonged to Pseudoalteromonas and Vibrio. Both genera are frequently recovered from the marine environment and aquaculture systems [18], [27][30] and are commonly associated with eukaryotic hosts [31], [32]. It is not known which antagonistic mechanisms were used by strains tested in the current study, however broad-spectrum anionic proteins and non-proteinaceous antibiotics produced by Pseudoalteromonas spp. [33], [34], and aliphatic hydroxyl ethers and andrimid antibiotics [30], [35] synthesised by Vibrio spp. are implicated in inhibition of aquatic vibrios.

Inhibition of planktonic V. owensii DY05 depended on both initial concentration and taxonomic grouping of the candidates. The results support previous studies showing that antagonists are generally required at higher concentrations than the pathogen for elimination [36][38]. Planktonic forms of all Vibrio and Pseudoalteromonas strains and the Ruegeria strain K2 strongly inhibited pathogen growth at the highest inoculum concentration. In contrast, the other strains (eg. Bacteroidetes and the other Ruegeria candidates) showed only moderate or low inhibition of planktonic pathogen growth despite showing antagonistic activity in well diffusion assays. This observation is consistent with several studies suggesting that free-living forms of marine bacteria may be less prone to producing antibacterials [26], [29]. Moreover, some compounds may only be bioactive during certain interactions. For example, Dheilly et al. [39] found anti-biofilm exoproducts of Pseudoalteromonas sp. 3J6 had no antibacterial properties against free-living Paracoccus and Vibrio strains.

Overall, the strongest biofilm inhibitory activity was seen in the exclusion assay, followed by the competition and displacement assays, respectively. This was probably due to the ability of bacteria such as Pseudoalteromonas and Ruegeria to rapidly form biofilms on the microwell surface and synthesise compounds with antifouling and antibacterial activity [20], [40], [41] that resist incoming pathogen propagules. The pigmented Pseudoalteromonas strains were the strongest inhibitors of pathogen attachment and pigmentation is known to be linked to production of bioactive molecules in this genus [40], [42]. Some Vibrio candidates (PP05 and PP25) were poor biofilm formers on the microwell surface yet were among the strongest inhibitors of pathogen attachment, suggesting inhibition was probably more related to the potency of the secreted compound rather than the biofilm biomass. Attached Bacteroidetes strains (AH26 and PPM04) were more successful than their planktonic conspecifics in outcompeting the pathogen, inferring an ecological preference for surface attachment and supporting a growing body of evidence that attached forms are more likely to exhibit antibacterial activity [29]. Reduced ability of probiotic candidates to displace pathogen biofilms could partly be related to the biofilm exopolymeric matrix trapping or slowing diffusion of antimicrobial compounds, leading to increased resistance [43], [44]. Biofilms may also tolerate antimicrobials through changes in genotypic pathways, including upregulation of genes encoding efflux pumps which facilitate the efflux of antimicrobials [45].

An experimental phyllosoma infection model was used to investigate if treatment with probiotic candidates could prevent or interrupt the infection cycle of V. owensii DY05 in P. ornatus phyllosoma. A pathogen exposure time of 6 h was selected, as previous studies using the phyllosoma infection model showed that V. owensii DY05 cells have entered the hepatopancreas at this time point [7]. However, as opportunistic carnivores [46], [47] some phyllosomas had not consumed all Artemia nauplii after 6 h, likely contributing to increased standard deviations relative to the robust and reproducible survival data produced in our previous study [7]. This can in part explain the discrepancies between the first two protection experiments (Figure 4b–c), where a significant protective benefit was recorded for separate treatments with Vibrio sp. PP05 or Pseudoalteromonas sp. PP107 in the first but not the second experiment.

An altered delivery strategy where the pathogen was added in combination with probiotic candidates during vectored transmission dramatically increased the protective benefit towards phyllosomas. Importantly, survival of phyllosomas receiving Vibrio sp. PP05 and Pseudoalteromonas sp. PP107 in combination did not differ significantly from non-treated controls across three replicated experiments (Figure 4d–f), and a reproducible survival enhancement (53–80%) was seen relative to pathogen controls. Pseudoalteromonas and Vibrio species have previously shown good potential as probiotics by enhancing survival of cultured invertebrates [33], [48], [49] and fish [50], [51] following challenge with pathogenic vibrios. However, horizontal gene transfer has contributed significantly to the evolution and dissemination of virulence genes in Vibrio genomes [52], so a certain amount of risk is involved in the selection of Vibrio probiotic strains. We consider the risk to be acceptable given the lack of evidence of probiotic vibrios acquiring virulence traits and the dramatically increased protective effect on phyllosomas when Vibrio sp. PP05 was included in the probiotic mixture. The possibility of transfer of virulence traits to PP05 does however exist, and this will have to be considered if disease outbreaks persist or re-emerge.

Multispecies probiotic applications have shown clear advantages over monospecies formulations in improving pathogen resistance also in previous studies [53]. At this stage it is not clear which mechanisms are responsible for the additive probiotic effects of PP05 and PP107 and this warrants further investigation.


Vibrio sp. PP05 and Pseudoalteromonas sp. PP107 were prospected from a large pool of antagonistic candidates based on their ability to inhibit planktonic and attached forms of pathogenic V. owensii DY05. Used in combination, these bacteria significantly and reproducibly protected P. ornatus phyllosomas from experimental infection with V. owensii DY05. Thus, the use of miniaturised co-culture and biofilm assays enabled rapid processing of numerous candidates and selection of probiotic bacteria capable of promoting survival. The study showed that natural microbial communities of wild phyllosomas support antagonistic bacteria capable of suppressing pathogens originating from the larviculture ecosystem and affirmed natural prey items as reservoirs of beneficial microorganisms.

Supporting Information Figure S1

Correlation between fluorescence and concentration (CFU mL−1) of V. owensii DY05[GFP] during 24 h monoculture growth.


Click here for additional data file (pone.0039667.s001.docx)

Table S1

Probiotic candidate shortlist.


Click here for additional data file (pone.0039667.s002.docx)

Protocol S1

Monostrain biofilm production assay.


Click here for additional data file (pone.0039667.s003.docx)


Competing Interests: The authors have declared that no competing interests exist.

Funding: EFG was supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

The authors wish to thank Lone Gram for kindly donating Phaeobacter strain 27-4. We also acknowledge the zootechnical assistance of Greg Smith, Matt Kenway, Matt Salmon, Grant Milton, Justin Hochen, Katie Holroyd, Jane Gioffre and Michael Clarkson (AIMS). Rochelle Soo, Rose Cobb, Brett Baillie and Sarah Castine are thanked for their technical assistance (all AIMS). The crew of the AIMS RV Cape Ferguson are also thanked for their assistance.

1. Kittaka J,Booth JD. Year: 2000Prospectus for aquaculture.Phillips BF,Kittaka J465473 Spiny lobster: Fisheries and culture.. Oxford: Fishing News Books..
2. Sabatini P. Year: 2010GLOBEFISH commodity update Lobster. Rome: Food and Agriculture Organization of the United Nations.35 p
3. Smith G,Salmon M,Kenway M,Hall M. Year: 2009Description of the larval morphology of captive reared Panulirus ornatus spiniy lobsters, benchmarked against wild-caught specimens.Aquaculture2957688
4. Bourne DG,Young N,Webster N,Payne M,Salmon M,et al. Year: 2004Microbial community dynamics in a larval aquaculture system of the tropical rock lobster, Panulirus ornatus.Aquaculture2423151
5. Bourne D,Høj L,Webster N,Payne M,Skindersøe M,et al. Year: 2007Microbiological aspects of phyllosoma rearing of the ornate rock lobster Panulirus ornatus.Aquaculture268274287
6. Webster NS,Bourne DG,Hall M. Year: 2006Vibrionaceae infection in phyllosomas of the tropical rock lobster Panulirus ornatus as detected by fluorescence in situ hybridisation Aquaculture255173178
7. Goulden EF,Hall MR,Bourne DG,Pereg LL,Høj L. Year: 2012Pathogenicity and infection cycle of Vibrio owensii in larviculture of ornate spiny lobster (Panulirus ornatus).Appl Environ Microbiol782841284922307306
8. Cano-Gomez A,Goulden EF,Owens L,Høj L. Year: 2010Vibrio owensii sp. nov., isolated from cultured crustaceans in Australia.FEMS Microbiol Lett30217518120002183
9. Davies J. Year: 2007Microbes have the last word.EMBO Rep861662117603533
10. Defoirdt T,Boon N,Sorgeloos P,Verstraete W,Bossier P. Year: 2007Alternatives to antibiotics to control bacterial infections: luminescent vibriosis in aquaculture as an example.Trends Biotechnol2547247917719667
11. Verschuere L,Rombaut G,Sorgeloos P,Verstraete W. Year: 2000Probiotic bacteria as biological control agents in aquaculture.Microbiol Mol Biol Rev6465567111104813
12. Vine NG,Leukes WD,Kaiser H. Year: 2006Probiotics in marine larviculture.FEMS Microbiol Rev3040442716594964
13. Kesarcodi-Watson A,Kaspar H,Lategan MJ,Gibson L. Year: 2008Probiotics in aquaculture: The need, principles and mechanisms of action and screening processes.Aquaculture274114
14. Defoirdt T,Sorgeloos P,Bossier P. Year: 2011Alternatives to antibiotics for the control of bacterial disease in aquaculture.Curr Opin Microbiol1425125821489864
15. Karunasagar I,Otta SK,Karunasagar I. Year: 1996Biofilm formation by Vibrio harveyi on surfaces.Aquaculture140241245
16. Bourne DG,Høj L,Webster NS,Swan J,Hall MR. Year: 2006Biofilm development within a larval rearing tank of the tropical rock lobster, Panulirus ornatus.Aquaculture2602738
17. Lynch AS,Robertson GT. Year: 2008Bacterial and fungal biofilm infections.Annu Rev Med5941542817937586
18. Hjelm M,Bergh Ø,Riaza A,Nielsen J,Melchiorsen J,et al. Year: 2004Selection and identification of autochthonous potential probiotic bacteria from turbot larvae (Scophthalmus maximus) rearing units.Syst Appl Microbiol2736037115214642
19. Bruhn JB,Nielsen KF,Hjelm M,Hansen M,Bresciani J,et al. Year: 2005Ecology, inhibitory activity, and morphogenesis of a marine antagonistic bacterium belonging to the Roseobacter clade.Appl Environ Microbiol717263727016269767
20. Bruhn JB,Gram L,Belas R. Year: 2007Production of antibacterial compounds and biofilm formation by Roseobacter species are influenced by culture conditions.Appl Environ Microbiol7344245017098910
21. Lane DJ. Year: 199116S/23S rRNA sequencing.Stackebrandt E,Goodfellow M115175 Nucleic Acid Techniques in Bacterial Systematics.. New York: John Wiley and Sons..
22. Tamura K,Dudley J,Nei M,Kumar S. Year: 2007MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0.Mol Biol Evol241596159917488738
23. Brewster JD. Year: 2003A simple micro-growth assay for enumerating bacteria.J Microbiol Meth537786
24. O’Toole GA,Pratt LA,Watnick PI,Newman DK,Weaver VB,et al. Year: 1999Genetic approaches to study biofilms.Methods Enzymol3109110910547784
25. Vesterlund S,Paltta J,Karp M,Ouwehand AC. Year: 2005Measurement of bacterial adhesion – in vitro evaluation of different methods.J Microbiol Meth60225233
26. Long RA,Azam F. Year: 2001Antagonistic interactions among marine pelagic bacteria.Appl Environ Microbiol674975498311679315
27. Makridis P,Martins S,Tsalavouta M,Dionisio LC,Kotoulas G,et al. Year: 2005Antimicrobial activity in bacteria isolated from Senegalese sole, Solea senegalensis, fed with natural prey.Aquacult Res3616191627
28. Fjellheim AJ,Playfoot KJ,Skjermo J,Vadstein O. Year: 2007Vibrionaceae dominates the microflora antagonistic towards Listonella anguillarum in the intestine of cultured Atlantic cod (Gadus morhua L.) larvae.Aquaculture26998106
29. Gram L,Melchiorsen J,Bruhn JB. Year: 2010Antibacterial activity of marine culturable bacteria collected from a global sampling of ocean surface waters and surface swabs of marine organisms.Mar Biotechnol1243945119823914
30. Wietz M,Mansson M,Gotfredsen CH,Larsen TO,Gram L. Year: 2010Antibacterial compounds from marine Vibrionaceae isolated on a global expedition.Mar Drugs82946296021339958
31. Thompson FL,Iida T,Swings J. Year: 2004Biodiversity of Vibrios.Microbiol Mol Biol Rev6840343115353563
32. Holmström C,Kjelleberg S. Year: 1999Marine Pseudoalteromonas species are associated with higher organisms and produce biologically active extracellular agents.FEMS Microbiol Ecol3028529310568837
33. Longeon A,Peduzzi J,Barthélemy M,Corre S,Nicolas J-L,et al. Year: 2004Purification and partial identification of novel antimicrobial protein from marine bacterium Pseudoalteromonas species strain X153.Mar Biotechnol663364115747093
34. Isnansetyo A,Istiqomah I,Muhtadi, Sinansari S,Hernawan RK,et al. Year: 2009A potential bacterial biocontrol agent, strain S2V2 against pathogenic marine Vibrio in aquaculture.World J Microbiol Biotechnol2511031113
35. Jorquera MA,Riquelme CE,Loyola LA,Muñoz LF. Year: 1999Production of bactericidal substances by a marine vibrio isolated from cultures of the scallop Argopecten purpuratus.Aquacult Int7433448
36. Gram L,Melchiorsen J,Spanggaard B,Huber I,Nielsen TF. Year: 1999Inhibition of Vibrio anguillarum by Pseudomonas fluorescens AH2, a possible probiotic treatment of fish.Appl Environ Microbiol6596997310049849
37. Vaseeharan B,Ramasamy P. Year: 2003Control of pathogenic Vibrio spp. by Bacillus subtilis BT23, a possible probiotic treatment for black tiger shrimp Penaeus monodon.Lett Appl Microbiol36838712535126
38. Jayaprakash NS,Pai SS,Anas A,Preetha R,Philip R,et al. Year: 2005A marine bacterium, Micrococcus MCCB 104, antagonistic to vibrios in prawn larval rearing systems.Dis Aquat Org68394516465832
39. Dheilly A,Soum-Soutéra E,Klein GL,Bazire A,Compère C,et al. Year: 2010Antibiofilm activity of the marine bacterium Pseudoalteromonas sp. strain 3J6.Appl Environ Microbiol763452346120363799
40. Holmström C,Egan S,Franks A,McCloy S,Kjelleberg S. Year: 2002Antifouling activities expressed by marine surface associated Pseudoalteromonas species.FEMS Microbiol Ecol41475819709238
41. Rao D,Webb JS,Kjelleberg S. Year: 2005Competitive interactions in mixed-species biofilms containing the marine bacterium Pseudoalteromonas tunicata.Appl Environ Microbiol711729173615811995
42. Egan S,James S,Holmström C,Kjelleberg S. Year: 2002Correlation between pigmentation and antifouling compounds produced by Pseudoalteromonas tunicata.Environ Microbiol443344212153584
43. Pasmore M,Costerton JW. Year: 2003Biofilms, bacterial signaling, and their ties to marine biology.J Ind Microbiol Biotechnol3040741312884126
44. Burmølle M,Webb JS,Rao D,Hansen LH,Sørensen SJ,et al. Year: 2006Enhanced biofilm formation and increased resistance to antimicrobial agents and bacterial invasion are caused by synergistic interactions in multispecies biofilms.Appl Environ Microbiol723916392316751497
45. Gillis RJ,White KG,Choe K-H,Wagner VE,Schweizer HP,et al. Year: 2005Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms.Antimicrob Agents Chemother493858386716127063
46. Suzuki N,Hoshino K,Murakami K,Takeyama H,Chow S. Year: 2008Molecular diet analysis of phyllosoma larvae of the Japanese spiny lobster Panulirus japonicus (Decapoda: Crustacea).Mar Biotechnol10495517955292
47. Chow S,Suzuki S,Matsunaga T,Lavery S,Jeffs A,et al. Year: 2010Investigation on natural diets of larval marine animals using peptide nucleic acid-directed polymerase chain reaction clamping.Mar Biotechnol1330531320535520
48. Riquelme C,Araya R,Vergara N,Rojas A,Guaita M,et al. Year: 1997Potential probiotic strains in the culture of Chilean scallop Argopecten purpuratus (Lamarck, 1819).Aquaculture1541726
49. Balcázar JL,Rojas-Luna T,Cunningham DP. Year: 2007Effect of the addition of four potential probiotic strains on the survival of pacific white shrimp (Litopenaeus vannamei) following immersion challenge with Vibrio parahaemolyticus.J Invert Pathol96147150
50. Austin B,Stuckey LF,Robertson PAW,Effendi I,Griffith DRW. Year: 1995A probiotic strain of Vibrio alginolyticus effective in reducing diseases caused by Aeromonas salmonicida, Vibrio anguillarum and Vibrio ordalii.J Fish Dis189396
51. Gatesoupe FJ. Year: 1997Siderophore production and probiotic effect of Vibrio sp. associated with turbot larvae, Scophthalmus maximus.Aquat Living Resour10239246
52. Hazen TH,Pan L,Gu J-D,Sobecky PA. Year: 2010The contribution of mobile genetic elements to the evolution and ecology of Vibrios.FEMS Microbiol Ecol7448549920662928
53. Timmerman HM,Koning CJM,Mulder L,Rombouts FM,Beynen AC. Year: 2004Monostrain, multistrain and multispecies probiotics - a comparison of functionality and efficacy.Int J Food Microbiol9621923315454313


[Figure ID: pone-0039667-g001]
doi: 10.1371/journal.pone.0039667.g001.
Figure 1  Microgrowth co-culture assay.

Inhibitory effect probiotic candidates on pathogen growth determined after 24 h co-culture, using fluorescence expressed by V. owensii DY05[GFP] as a proxy for its planktonic growth. The initial pathogen concentration was 1×103 CFU mL−1, while initial probiont concentrations were (a) 1×103 CFU mL−1, (b) 1×105 CFU mL−1, or (c) 1×107 CFU mL−1. Green: low activity (<50% of max); Yellow: moderate activity (50–75% of max); Red: strong activity (>75% of max).

[Figure ID: pone-0039667-g002]
doi: 10.1371/journal.pone.0039667.g002.
Figure 2  Monostrain biofilm formation.

A crystal violet-microwell assay was used to assess monospecies biofilm formation of V. owensii DY05, V. owensii DY05[GFP] and probiotic candidate isolates belonging to Vibrio (C013, Ma31, PP05, and PP25), Pseudoalteromonas (EPP07, K25, PP107, EPP11, PP81, PP86, and PP87), Ruegeria (AH10, K2, and EPP04), and Bacteroidetes (AH26 and PPM04).

[Figure ID: pone-0039667-g003]
doi: 10.1371/journal.pone.0039667.g003.
Figure 3  Multistrain biofilm interactions.

Inhibitory effect of probiotic candidates on pathogen biofilm formation under conditions of (a) exclusion, (b) competition and (c) displacement using fluorescence expressed by V. owensii DY05[GFP] as a proxy for pathogen attachment. Strains that appeared to facilitate pathogen biofilm formation are not presented. Columns represent average values from two time points (t = 48 h and t = 72 h). Green: low activity (<50% of max); Yellow: moderate activity (50–75% of max); Red: strong activity (>75% of max).

[Figure ID: pone-0039667-g004]
doi: 10.1371/journal.pone.0039667.g004.
Figure 4  Pathogenicity testing and protective benefit of probiotic candidates on pathogen challenged P. ornatus phyllosomas.

(a) Pathogenicity testing of probiotic candidates. Vibrio sp. PP05 (•), Pseudoalteromonas sp. PP107 (▪), Pseudoalteromonas sp. K25 (▾), or Ruegeria sp. K2 (♦), unchallenged control (○), V. owensii DY05 pathogen control (×). (b) Protective benefit of probiotic candidates towards V. owensii DY05 challenged phyllosomas using Administration Strategy 1. PP05 (•), PP107 (▪), K25 (▾), K2 (♦), a mixture of the four candidates (▴), unchallenged control (○), pathogen control (×). (c) Protective benefit of probiotic candidates towards V. owensii DY05 challenged phyllosomas using Administration Strategy 1. PP05 (•), PP107 (▾), PP05+ PP107 (▪), unchallenged control (○), pathogen control (×). (d) Protective benefit of probiotic candidates towards V. owensii DY05 challenged phyllosomas using Administration Strategy 2. PP05 (•), PP107 (▾), PP05+ PP107 (▪), unchallenged control (○), pathogen control (×). (e-f) Replicate experiments showing protective benefit of probiotic candidates towards V. owensii DY05 challenged phyllosomas using Administration Strategy 2. PP05+ PP107 (▪), unchallenged control (○), pathogen control (×). Phyllosoma survival expressed as Means ± SD.

Article Categories:
  • Research Article
Article Categories:
  • Agriculture
    • Aquaculture
      • Mariculture
Article Categories:
  • Biology
    • Computational Biology
      • Population Modeling
        • Infectious Disease Modeling
    • Microbiology
      • Bacterial Pathogens
        • Gram Negative
      • Bacteriology
        • Bacterial Biofilms
      • Applied Microbiology
      • Microbial Control
      • Microbial Ecology

Previous Document:  HCV genotypes are differently prone to the development of resistance to linear and macrocyclic prote...
Next Document:  Combinatorial action of miRNAs regulates transcriptional and post-transcriptional gene silencing fol...